August 15th 2025
The INTEGUMENT-OLE study is an open-label extension analysis that followed a primary investigation from the phase 3 INTEGUMENT-PED trial, which investigated the efficacy and safety of once-daily roflumilast cream 0.05% for atopic dermatitis in children aged 2 to 5 years.
Out-of-Pocket Rx Costs Two Times Higher in Silver Plans Than Employer Plans
October 22nd 2015Out-of-pocket expenses for medications in typical silver plans are twice as high as they are in employer-sponsored plans, leading patients to fill and refill medications less frequently, which has important health implications.
Read More
What We're Reading: Duke University's New Health Policy Center
October 20th 2015What we're reading, October 20, 2015: Mark McClellan, MD, PhD, will lead Duke's Center for Health Policy; the eligible uninsured will face higher fines in 2016; and Canadian researchers use digital media to improve quality and care outcomes.
Read More
HHS Lowballs Marketplace Enrollment Expectations for 2016
October 17th 2015By the end of 2016, 10 million people are expected to have insurance coverage through the health insurance marketplaces and be paying their premiums, which is a small increase from the current 9.1 million individuals.
Read More
Retail Clinics Should Be Used as Backup to Primary Care Physician, ACP Says
October 15th 2015Patients are embracing and exploring alternatives to the traditional office practice, and the expansion of retail health clinics is a big part of that. However, the American College of Physicians said these clinics are best used as a backup alternative to a primary care physician.
Read More